Elijah Darnell

Elijah Darnell is an Assistant Professor at the University of Chicago in the Department of Medicine-Hematology and Oncology. He specializes in the treatment of B- and T-cell lymphomas and chronic lymphocytic leukemia (CLL), with a focus on clinical investigation of novel agents such as CAR T-cell therapy, bispecific antibodies, and targeted immune therapies. Dr. Darnell leads research initiatives to develop functional characterizations of immunity in CLL patients to improve infection prevention strategies.

Research Trends: His work bridges immunology and hematology-oncology, emphasizing translational approaches to enhance cancer treatment efficacy through immune modulation. The 2020 publication on cytokine signatures in olfactory dysfunction highlights his interest in biomarker discovery.